Glenmark Pharma is divesting a significant 75% stake in its subsidiary, Glenmark Life Sciences, to Nirma, known for its washing powder products, in a deal valued at Rs. 5,652 crores. This strategic move likely allows Glenmark Pharma to focus on its core pharmaceutical operations while providing Nirma an entry into the pharmaceutical sector. The transaction reflects a major development in India’s business landscape.
Follow Taxpuram to stay updated with current news
Recent Comments